Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Didier Matray | M | 73 |
University of Liege
| 32 years |
| Bruno Boulanger | M | - |
University of Liege
| 24 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Barry James Price | M | 80 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 12 years |
| Richard Storer | M | 76 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 6 years |
| David Ummels | M | - |
University of Liege
| 10 years |
| Andrew Richards | M | 64 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
| Steven Lee | M | 57 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | - |
| George Elliott | M | 71 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
| Vincent Marville | M | - |
University of Liege
| 5 years |
| Pierre-Yves Collée | M | 49 |
University of Liege
| 8 years |
| Daniel Marechal | M | - |
University of Liege
| 3 years |
| Marc Biron | M | 54 |
University of Liege
| 3 years |
| Pascal Keutgens | M | - |
University of Liege
| 5 years |
| Michelle Deberg | M | - |
University of Liege
| 3 years |
| Marc Foidart | M | - |
University of Liege
| 1 years |
| Jean-Pierre Verlaine | M | - |
University of Liege
| 2 years |
| Robert Brzusczak | M | 70 |
University of Liege
| 4 years |
| Nikkolaos Antimissaris | M | 55 |
University of Liege
| 4 years |
| Soumya Chandramouli | F | 46 |
University of Liege
| 4 years |
| Nathalie Thunus | F | - |
University of Liege
| 4 years |
| Eric Paskoff | M | 58 |
University of Liege
| 2 years |
| Éric Reiter | M | - |
University of Liege
| 3 years |
| Denis Goffaux | M | 57 |
University of Liege
| 4 years |
| Valérie Gordenne | F | 51 |
University of Liege
| 4 years |
| Jonathon Tinsley | M | 65 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 13 years |
| Patricia Vangeel | F | - |
University of Liege
| 4 years |
| Bernard Stas | M | - |
University of Liege
| 1 years |
| Lamia Tazi | F | 47 |
University of Liege
| 4 years |
| Patrice Filée | M | - |
University of Liege
| 3 years |
| Fabrizio Giannotta | M | - |
University of Liege
| 3 years |
| Pierre Jacquet | M | 57 |
University of Liege
| 3 years |
| Christine D. Franquin | F | - |
University of Liege
| 3 years |
| Gilles-Olivier Moury | M | - |
University of Liege
| 4 years |
| Colin David Wall | M | 74 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 3 years |
| Darren Millington | M | - |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 3 years |
| Denis Hermesse | M | 54 |
University of Liege
| 4 years |
| James Taylor | M | 60 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | - |
| Dimitri Liquet | M | - |
University of Liege
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 29 | 76.32% |
| United Kingdom | 9 | 23.68% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephane Berghmans
- Personal Network
